Literature DB >> 16482806

[Endemic level of congenital Trypanosoma cruzi infection in the areas of maternal residence and the development of congenital Chagas disease in Bolivia].

Faustino Torrico1, Cristina Alonso-Vega, Eduardo Suarez, Patricia Rodríguez, Mary-Cruz Torrico, Michele Dramaix, Carine Truyens, Yves Carlier.   

Abstract

In Bolivia, the prevalence of infection by T. cruzi in women in fertile age can vary between 20 and 60%. The present study made in the Maternity Germin Urquidi of Cochabamba - Bolivia, it has demonstrated, that 19.9% of the mothers who go to this hospitable center to be taken care of in the childbirth, they are carrying of the infection and that 4,6% of them, they are going to transmit, by transplacentaria route, the infection to its babies. Of the 71 children born with congenital Chagas, only 47,8 % present/display some type of alteration or of development(Apgar to 1 minute low, BPN, prematuridad, pathological dismadurez) or signs (SDR, hepatomegalia, esplenomegalia, neurological signs, cardiomegalia, anasarca, petequias). When investigating the effect of the differences in the vectorial density (low, medium and high) of the zone of maternal residence, on the transmission of the infection of the mother infected to the fetus, we concluded that the rate of transmission of the congenital infection of T. cruzi is not modified by the level of endemicidad of the zone of maternal residence. By another infected new born sides whose mothers reside in zones of high endemicidad present/display, most frequently and of significant way, Apgar to 1 minute < to 7, low weight when being born and prematuridad or an association of these alterations with respiratory syndrome of distress or anasarca, when one compares them with new born of resident mothers in the zones of loss or medium endemicidad, mortality in this group is greater. These results suggest calls to account it of the mothers, in areas of high endemicidad, she is associate with a serious increase in the risk of Disease of newborn severe and mortal congenital Chagas in.

Entities:  

Mesh:

Year:  2005        PMID: 16482806

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

1.  Prevalence and risk factors for Chagas disease in pregnant women in Casanare, Colombia.

Authors:  Zulma M Cucunubá; Astrid C Flórez; Angela Cárdenas; Paula Pavía; Marleny Montilla; Rodrigo Aldana; Katherine Villamizar; Lyda C Ríos; Rubén S Nicholls; Concepción J Puerta
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

Review 2.  Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis.

Authors:  E J Howard; X Xiong; Y Carlier; S Sosa-Estani; P Buekens
Journal:  BJOG       Date:  2013-08-07       Impact factor: 6.531

Review 3.  Impact of chagas disease in bolivian immigrants living in europe and the risk of stigmatization.

Authors:  Rafael M Ortí-Lucas; María C Parada-Barba; José E de la Rubia-Ortí; Alejandra Carrillo-Ruiz; María Beso-Delgado; An L D Boone
Journal:  J Parasitol Res       Date:  2014-02-27

4.  Pacemaker Implants in Children and Adolescents with Chagas Disease in Brazil: 18-Year Incidence.

Authors:  Carolina Christianini Mizzaci; Thiago Gonçalves Schroder E Souza; Gabriel Pelegrineti Targueta; Ana Paula Frederico Tótora; Juan Carlos Pachón Mateos; José Carlos Pachon Mateos
Journal:  Arq Bras Cardiol       Date:  2017-06       Impact factor: 2.000

5.  Congenital transmission of Chagas disease in Latin American immigrants in Switzerland.

Authors:  Yves Jackson; Catherine Myers; Alessandro Diana; Hans Peter Marti; Hans Wolff; François Chappuis; Louis Loutan; Alain Gervaix
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

6.  Risk factors associated with Chagas disease in pregnant women in Santander, a highly endemic Colombian area.

Authors:  Yeny Z Castellanos-Domínguez; Zulma M Cucunubá; Luis C Orozco; Carlos A Valencia-Hernández; Cielo M León; Astrid C Florez; Lyda Muñoz; Paula Pavía; Marleny Montilla; Luz Marina Uribe; Carlos García; William Ardila; Rubén Santiago Nicholls; Concepción J Puerta
Journal:  Trop Med Int Health       Date:  2015-12-01       Impact factor: 2.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.